|
Journal of Lipid Research, Vol. 41, 521-531, April 2000
Copyright © 2000 by Lipid Research, Inc.
Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis
Susanne M. Cleea,
Nagat Bissadaa,
Fudan Miaoa,
Li Miaoa,
A. David Maraisb,
Howard E. Hendersonc,
Pieternel Steuresa,
Janet McManusd,
Bruce McManusd,
Renee C. LeBoeufe,
John J. P. Kasteleinf, and
Michael R. Haydena
a Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada V5Z 4H4
b Department of Internal Medicine, University of Cape Town, Cape Town, 7925 South Africa
c Department of Clinical Pathology, Red Cross Children's Hospital, Cape Town, 7700 South Africa
d Department of Pathology and Laboratory Medicine, St. Paul's Hospital-University of British Columbia, Vancouver, Canada V6Z 1Y6
e Department of Pathobiology, University of Washington, Seattle, WA 98195
f Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands 1105 AZ
Correspondence to:
Michael R. Hayden
Lipoprotein lipase (LPL) is a key enzyme in lipoprotein metabolism, and has been hypothesized to exert either pro- or anti-atherogenic effects, depending on its localization. Decreased plasma LPL activity is associated with the high triglyceride (TG);low HDL phenotype that is often observed in patients with premature vascular disease. In contrast, in the vessel wall, decreased LPL may be associated with less lipoprotein retention due to many potential mechanisms and, therefore, decreased foam cell formation. To directly assess this hypothesis, we have distinguished between the effects of variations in plasma and/or vessel wall LPL on atherosclerosis susceptibility in apoE-deficient mice. Reduced LPL in both plasma and vessel wall (LPL+/- E-/-) was associated with increased TG and increased total cholesterol (TC) compared with LPL+/+E-/- sibs. However despite their dyslipidemia, LPL+/-E-/- mice had significantly reduced lesion areas compared to the LPL+/+E-/- mice. Thus, decreased vessel wall LPL was associated with decreased lesion formation even in the presence of reduced plasma LPL activity. In contrast, transgenic mice with increased plasma LPL but with no increase in LPL expression in macrophages, and thus the vessel wall, had decreased TG and TC and significantly decreased lesion areas compared with LPL+/+E-/- mice. This demonstrates that increased plasma LPL activity alone, in the absence of an increase in vessel wall LPL, is associated with reduced susceptibility to atherosclerosis.
Taken together, these results provide in vivo evidence that the contribution of LPL to atherogenesis is significantly influenced by the balance between vessel wall protein (pro-atherogenic) and plasma activity (anti-atherogenic).Clee, S. M., N. Bissada, F. Miao, L. Miao, A. D. Marais, H. E. Henderson, P. Steures, J. McManus, B. McManus, R. C. LeBoeuf, J. J. P. Kastelein, and M. R. Hayden. Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis. J. Lipid Res. 2000. 41: 521;531.
Supplementary key words:
apoE-deficient mice, triglycerides, HDL, lipoprotein retention, C57BL/6

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Maingrette, L. Li, and G. Renier
C-reactive protein enhances macrophage lipoprotein lipase expression
J. Lipid Res.,
September 1, 2008;
49(9):
1926 - 1935.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhang, R. Qi, X. Xian, F. Yang, M. Blackstein, X. Deng, J. Fan, C. Ross, J. Karasinska, M. R. Hayden, et al.
Spontaneous Atherosclerosis in Aged Lipoprotein Lipase-Deficient Mice With Severe Hypertriglyceridemia on a Normal Chow Diet
Circ. Res.,
February 1, 2008;
102(2):
250 - 256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tabas, K. J. Williams, and J. Boren
Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications
Circulation,
October 16, 2007;
116(16):
1832 - 1844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, X. Xian, W. Huang, L. Chen, L. Wu, Y. Zhu, J. Fan, C. Ross, M. R. Hayden, and G. Liu
Expression of LPL in Endothelial-Intact Artery Results in Lipid Deposition and Vascular Cell Adhesion Molecule-1 Upregulation in Both LPL and ApoE-Deficient Mice
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2007;
27(1):
197 - 203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rip, M. C. Nierman, C. J. Ross, J. W. Jukema, M. R. Hayden, J. J.P. Kastelein, E. S.G. Stroes, and J. A. Kuivenhoven
Lipoprotein Lipase S447X: A Naturally Occurring Gain-of-Function Mutation
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2006;
26(6):
1236 - 1245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K. Curtiss, D. T. Valenta, N. J. Hime, and K.-A. Rye
What Is So Special About Apolipoprotein AI in Reverse Cholesterol Transport?
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2006;
26(1):
12 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J.D. Ross, G. Liu, J. A. Kuivenhoven, J. Twisk, J. Rip, W. van Dop, K. J.D. Ashbourne Excoffon, S. M.E. Lewis, J. J. Kastelein, and M. R. Hayden
Complete Rescue of Lipoprotein Lipase-Deficient Mice by Somatic Gene Transfer of the Naturally Occurring LPLS447X Beneficial Mutation
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2005;
25(10):
2143 - 2150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shimokawa, K.-i. Hirata, T. Ishida, Y. Kojima, N. Inoue, T. Quertermous, and M. Yokoyama
Increased expression of endothelial lipase in rat models of hypertension
Cardiovasc Res,
June 1, 2005;
66(3):
594 - 600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Maingrette and G. Renier
Leptin Increases Lipoprotein Lipase Secretion by Macrophages: Involvement of Oxidative Stress and Protein Kinase C
Diabetes,
August 1, 2003;
52(8):
2121 - 2128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. Capell, C. A. DeSouza, P. Poirier, M. L. Bell, B. L. Stauffer, K. M. Weil, T. L. Hernandez, and R. H. Eckel
Short-Term Triglyceride Lowering With Fenofibrate Improves Vasodilator Function in Subjects With Hypertriglyceridemia
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2003;
23(2):
307 - 313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Askari, M. A. Carroll, M. Capparelli, F. Kramer, R. G. Gerrity, and K. E. Bornfeldt
Oleate and Linoleate Enhance the Growth-promoting Effects of Insulin-like Growth Factor-I through a Phospholipase D-dependent Pathway in Arterial Smooth Muscle Cells
J. Biol. Chem.,
September 20, 2002;
277(39):
36338 - 36344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R Mead and D. P Ramji
The pivotal role of lipoprotein lipase in atherosclerosis
Cardiovasc Res,
August 1, 2002;
55(2):
261 - 269.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Hughes, T. S. Tengku-Muhammad, S. A. Irvine, and D. P. Ramji
A Novel Role of Sp1 and Sp3 in the Interferon-gamma -mediated Suppression of Macrophage Lipoprotein Lipase Gene Transcription
J. Biol. Chem.,
March 22, 2002;
277(13):
11097 - 11106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Schneider, J. Kreuzer, A. Hamann, P. P. Nawroth, and K. A. Dugi
The Proline 12 Alanine Substitution in the Peroxisome Proliferator-Activated Receptor-{gamma}2 Gene Is Associated With Lower Lipoprotein Lipase Activity in Vivo
Diabetes,
March 1, 2002;
51(3):
867 - 870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. Pentikainen, R. Oksjoki, K. Oorni, and P. T. Kovanen
Lipoprotein Lipase in the Arterial Wall: Linking LDL to the Arterial Extracellular Matrix and Much More
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2002;
22(2):
211 - 217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wilson, G. L. Fry, D. A. Chappell, C. D. Sigmund, and J. D. Medh
Macrophage-Specific Expression of Human Lipoprotein Lipase Accelerates Atherosclerosis in Transgenic Apolipoprotein E Knockout Mice but Not in C57BL/6 Mice
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2001;
21(11):
1809 - 1815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shimo-Nakanishi, T. Urabe, N. Hattori, Y. Watanabe, T. Nagao, M. Yokochi, M. Hamamoto, and Y. Mizuno
Polymorphism of the Lipoprotein Lipase Gene and Risk of Atherothrombotic Cerebral Infarction in the Japanese
Stroke,
July 1, 2001;
32(7):
1481 - 1486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Boren, A. Lookene, E. Makoveichuk, S. Xiang, M. Gustafsson, H. Liu, P. Talmud, and G. Olivecrona
Binding of Low Density Lipoproteins to Lipoprotein Lipase Is Dependent on Lipids but Not on Apolipoprotein B
J. Biol. Chem.,
July 13, 2001;
276(29):
26916 - 26922.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|